Filing Details
- Accession Number:
- 0001140361-15-042195
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-11-18 17:10:01
- Reporting Period:
- 2015-11-16
- Filing Date:
- 2015-11-18
- Accepted Time:
- 2015-11-18 17:10:01
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1048477 | Biomarin Pharmaceutical Inc | BMRN | Pharmaceutical Preparations (2834) | 680397820 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1247681 | Bryan V Lawlis | C/O Biomarin Pharmaceutical Inc. 105 Digital Drive Novato CA 94949 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2015-11-16 | 1,050 | $104.26 | 11,850 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2015-11-16 | 7,500 | $17.33 | 19,350 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2015-11-16 | 7,500 | $107.27 | 11,850 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) common stock | Disposition | 2015-11-16 | 7,500 | $0.00 | 7,500 | $17.33 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 22,500 | 2007-12-07 | 2017-06-06 | No | 4 | M | Direct |
Footnotes
- Trade made pursuant to a 10b5-1 plan executed on August 24, 2015.
- The price in column 4 is an average weighted price. The price actually received ranged from $103.07 to $106.12. The issuing person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- The price in column 4 is a weighted average price. The price actually received ranged from $102.98 to $106.81. The reporting person shall provide to the issuer, and security holder of the issuer, or the SEC staff upon request, information regarding the number of shares sold at each price within the range.
- Original option grant vests 6/48ths on December 7, 2007, and 1/48th on the 7th day of every month thereafter.
- Reflects the number of stocks options that remain outstanding from this specific stock option grant following the reported transaction.
Billionaire Hedge Funds
